News

First Digital Europe calls open on 15 April 2025

Published on | 9 months ago

Programmes Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies European Digital Innovation Hubs

The upcoming calls from the Digital Europe Main Work Programme have been published on the Funding & Tenders Portal of the European Commission. 

The following 10 call topics are expected to open for submission on 15 April 2025, deadline to submit proposals will be 2 September 2025:

AI, data & cloud

Advanced Digital Skills

Deployment - Accelerating best use of digital technologies

 

Furthermore, a call aiming at the Consolidation of the network of European Digital Innovation Hubs (EDIHs with reinforced AI focus) will open on 3 April 2025 and close on 14 May 2025.

NCP Flanders organises an info session on these upcoming calls on 14 April. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1781 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.